Biotech, a medical imaging and modeling company, must purchase a bone cell analysis system for use by a team of bioengineers and mechanical engineers studying bone density in athletes. This particular part of a 3-year contract with the NBA will provide additional gross income of $100,000 per year. The effective tax rate is 35%.
|
Analyzer 1
|
Analyzer 2
|
First cost, $
|
150,000
|
225,000
|
Operating expenses, $ per year
|
30,000
|
10,000
|
MACRS recovery, years
|
5
|
5
|
a. The Biotech president, who is very tax conscious, wishes to use a criterion of minimizing total taxes incurred over the 3 years of the contract. Which analyzer should be purchased?
b. Assume that after 3 years the company will sell the selected analyzer. Using the same total tax criterion, does either analyzer have an advantage? The selling prices are expected to be $130,000 for analyzer 1 and $225,000 for analyzer 2.